Related Experiment Video
Updated: Jul 3, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Universal access to HIV treatment in developing countries: going beyond the misinterpretations of the
Jean Paul Moatti1, Richard Marlink, Stephane Luchini
1University of the Mediterranean, Marseilles, France. moatti@marseille.inserm.fr
AIDS (London, England)
|August 2, 2008
Summary
Cost-effectiveness analysis (CEA) has limitations for prioritizing HIV/AIDS interventions. A pragmatic approach, considering societal and ethical factors alongside cost per life-year saved, is recommended for resource allocation.
Area of Science:
- Health Economics
- Public Health Policy
- Epidemiology
Background:
- Cost-effectiveness analysis (CEA) is a proposed tool for health intervention priority setting.
- Debates persist regarding the application of CEA in HIV/AIDS resource allocation.
Purpose of the Study:
- To review health and public economics literature on CEA for public health priority setting.
- To inform discussions on resource allocation for HIV/AIDS interventions.
Main Methods:
- Literature review of economic analyses.
- Examination of theoretical and practical limitations of CEA.
- Analysis of CEA application in public health and HIV/AIDS.
Main Results:
- CEA is effective for comparing interventions for the same condition.
- Ranking interventions by cost per life-year saved is problematic due to unrealistic assumptions.
- A pragmatic interpretation of CEA, considering interventions with marginal costs < 3x GDP per capita as cost-effective, is more suitable for HIV/AIDS programs.
Conclusions:
- CEA results have empirical and theoretical limitations.
- CEA should be one component of HIV/AIDS intervention priority setting.
- Societal and ethical preferences must also inform resource allocation decisions.
More Related Videos
Related Concept Videos
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:30Primary Healthcare Services
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...